Published in Am J Pathol on June 01, 2002
Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev (2007) 5.95
Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest (2007) 1.87
Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet (2008) 1.64
PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol (2008) 1.63
Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res (2009) 1.38
Retracted Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem (2009) 1.33
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
DOT1L regulates dystrophin expression and is critical for cardiac function. Genes Dev (2011) 1.25
Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome (2006) 1.03
Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies. Can J Cardiol (2006) 1.00
Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics (2009) 0.98
Sex- and age-dependent human transcriptome variability: implications for chronic heart failure. Proc Natl Acad Sci U S A (2003) 0.96
Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy. Comp Funct Genomics (2004) 0.92
Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Cardiovasc Diabetol (2011) 0.92
The 'thousand-dollar genome': an ethical exploration. Eur J Hum Genet (2013) 0.92
Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. PLoS One (2013) 0.91
Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Can J Cardiol (2007) 0.90
Genome informatics: current status and future prospects. Circ Res (2003) 0.88
Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy. PLoS One (2012) 0.88
Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans. Eur Heart J (2015) 0.87
Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue. J Cell Mol Med (2012) 0.87
Cleavage of serum response factor mediated by enteroviral protease 2A contributes to impaired cardiac function. Cell Res (2011) 0.86
Expression profiling of cardiovascular disease. Hum Genomics (2004) 0.84
Microarray analysis: a novel research tool for cardiovascular scientists and physicians. Heart (2003) 0.84
Serial gene expression profiling in the intact human heart. J Heart Lung Transplant (2006) 0.83
Mena associates with Rac1 and modulates connexin 43 remodeling in cardiomyocytes. Am J Physiol Heart Circ Physiol (2013) 0.81
Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. J Heart Lung Transplant (2007) 0.81
Genomics, proteomics and bioinformatics of human heart failure. J Muscle Res Cell Motil (2003) 0.80
Gene expression profiling: from microarrays to medicine. J Clin Immunol (2004) 0.80
Identification of gene co-regulatory modules and associated cis-elements involved in degenerative heart disease. BMC Med Genomics (2009) 0.78
Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis. Histochem Cell Biol (2011) 0.78
Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy. PLoS One (2016) 0.77
Recent progress in histochemistry and cell biology. Histochem Cell Biol (2012) 0.76
Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure. Basic Res Cardiol (2016) 0.75
Hierarchical approaches for systems modeling in cardiac development. Wiley Interdiscip Rev Syst Biol Med (2013) 0.75
Identification of the molecular mechanisms underlying dilated cardiomyopathy via bioinformatic analysis of gene expression profiles. Exp Ther Med (2016) 0.75
The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure. Sci Rep (2017) 0.75
A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. PLoS One (2017) 0.75
Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins. J Recept Signal Transduct Res (2013) 0.75
The Role of Leucine-Rich Repeat Containing Protein 10 (LRRC10) in Dilated Cardiomyopathy. Front Physiol (2016) 0.75
Proteostasis in cardiac health and disease. Nat Rev Cardiol (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell (2000) 36.09
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell (1990) 5.77
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell (1994) 4.47
Stress pathways and heart failure. Cell (1999) 3.80
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A (2000) 2.45
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med (2000) 2.04
Genomic circuits and the integrative biology of cardiac diseases. Nature (2000) 1.70
Cardiac intracellular calcium release channels: role in heart failure. Circ Res (2000) 1.62
The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol (1998) 1.61
Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun (1999) 1.48
Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res (1998) 1.44
Cardiac hypertrophy: sorting out the circuitry. Curr Opin Genet Dev (1999) 1.40
A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation (1997) 1.38
Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy. J Biol Chem (2000) 1.36
Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet (2001) 1.27
A catalogue of genes in the cardiovascular system as identified by expressed sequence tags. Proc Natl Acad Sci U S A (1994) 1.23
Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics (2000) 1.18
Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C. Biochem J (2000) 1.10
Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res (2000) 1.07
Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun (2001) 0.94
Changing the remodeling process in heart failure: basic mechanisms and laboratory results. Curr Opin Cardiol (1998) 0.93
Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system. J Mol Cell Cardiol (1994) 0.91
Genetic abnormalities responsible for dilated cardiomyopathy. Curr Cardiol Rep (2000) 0.83
Genomics and the pathophysiology of heart failure. Curr Cardiol Rep (2001) 0.83
Construction of a human heart cDNA library and identification of cardiovascular based genes (CVBest). Mol Cell Biochem (1997) 0.80
Molecular regulation of phospholamban function and gene expression. Ann N Y Acad Sci (1998) 0.79
A cardiovascular EST repertoire: progress and promise for understanding cardiovascular disease. Mol Med Today (2000) 0.78
Controlling myocardial matrix remodeling: implications for heart failure. Cardiol Rev (1999) 0.78
Timing of new black box warnings and withdrawals for prescription medications. JAMA (2002) 9.65
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther (2006) 2.85
Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A (2005) 2.29
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation (2003) 2.27
Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology (2006) 1.97
An initiative in mentoring to promote residents' and faculty members' careers. Acad Med (2004) 1.95
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol (2010) 1.95
Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension (2006) 1.91
The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med (2007) 1.91
Atherosclerosis 2005: recent discoveries and novel hypotheses. Circulation (2005) 1.87
Cloning and characterization of a novel cardiac-specific kinase that interacts specifically with cardiac troponin I. J Mol Med (Berl) (2003) 1.79
Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J Physiol (2007) 1.78
Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene (2004) 1.77
Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell (2007) 1.72
A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer (2010) 1.70
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation (2002) 1.67
Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J (2010) 1.67
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res (2010) 1.60
Molecular genetics and genomics of heart failure. Nat Rev Genet (2004) 1.60
Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors. Nat Neurosci (2011) 1.58
Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U S A (2009) 1.57
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics (2002) 1.57
Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol (2008) 1.55
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol (2002) 1.53
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci U S A (2004) 1.51
Cell cycle-dependent regulation of smooth muscle cell activation. Arterioscler Thromb Vasc Biol (2004) 1.51
Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.51
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells (2009) 1.50
Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J Biol Chem (2007) 1.48
Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res (2006) 1.46
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation (2004) 1.46
Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res (2006) 1.44
Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation (2004) 1.41
Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem (2003) 1.38
Improving the health of the community: Duke's experience with community engagement. Acad Med (2008) 1.38
Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle. Am J Physiol Cell Physiol (2004) 1.36
Gene expression profile of zebrafish exposed to hypoxia during development. Physiol Genomics (2003) 1.35
Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol (2008) 1.35
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
Structural characterization of the RyR1-FKBP12 interaction. J Mol Biol (2005) 1.30
Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol (2004) 1.28
Age-related hearing loss in C57BL/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J Assoc Res Otolaryngol (2007) 1.27
Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia (2012) 1.26
Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J Biol Chem (2007) 1.25
Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle. Biophys J (2002) 1.23
The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A (2002) 1.23
Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation (2004) 1.22
Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem (2007) 1.22
Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc Natl Acad Sci U S A (2006) 1.22
Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther (2010) 1.19
RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes. J Biol Chem (2010) 1.18
Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism. J Biol Chem (2003) 1.17
Perspective: global medicine: opportunities and challenges for academic health science systems. Acad Med (2011) 1.17
Identification of a region of RyR1 that participates in allosteric coupling with the alpha(1S) (Ca(V)1.1) II-III loop. J Biol Chem (2001) 1.15
Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol (2007) 1.15
Training the next generation of physician-executives: an innovative residency pathway in management and leadership. Acad Med (2011) 1.14
Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol (2006) 1.14
Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest (2005) 1.13
Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. FASEB J (2006) 1.13
Increased resting intracellular calcium modulates NF-κB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes. J Biol Chem (2012) 1.13
Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A (2012) 1.12
Homer regulates gain of ryanodine receptor type 1 channel complex. J Biol Chem (2002) 1.12
Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion. J Biol Chem (2005) 1.11
SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional autofeedback loop of Wnt3a. Stem Cells (2007) 1.09
Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol (2003) 1.09
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci U S A (2004) 1.09
Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J (2006) 1.09
Alpha2delta1 dihydropyridine receptor subunit is a critical element for excitation-coupled calcium entry but not for formation of tetrads in skeletal myotubes. Biophys J (2008) 1.09
Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol Genomics (2003) 1.06
Nuclear receptor LXRalpha is involved in cAMP-mediated human renin gene expression. Mol Cell Endocrinol (2004) 1.06
RyR1 and RyR3 isoforms provide distinct intracellular Ca2+ signals in HEK 293 cells. J Cell Sci (2002) 1.04
Triadin/Junctin double null mouse reveals a differential role for Triadin and Junctin in anchoring CASQ to the jSR and regulating Ca(2+) homeostasis. PLoS One (2012) 1.04
The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell (2003) 1.04
TRPC3-interacting triadic proteins in skeletal muscle. Biochem J (2008) 1.04
A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR. J Gen Physiol (2010) 1.02
N-terminal region of FKBP12 is essential for binding to the skeletal ryanodine receptor. J Biol Chem (2004) 1.02
Paradoxical buffering of calcium by calsequestrin demonstrated for the calcium store of skeletal muscle. J Gen Physiol (2010) 1.02
Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development. Biochem Biophys Res Commun (2002) 1.01
Amino acids 1-1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain D2. J Biol Chem (2003) 1.01
Orthograde dihydropyridine receptor signal regulates ryanodine receptor passive leak. Proc Natl Acad Sci U S A (2011) 1.00
Endothelium-targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vasc Biol (2004) 0.99
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation (2002) 0.98
RyR1/RyR3 chimeras reveal that multiple domains of RyR1 are involved in skeletal-type E-C coupling. Biophys J (2003) 0.98
A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels. J Gen Physiol (2010) 0.98
Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol Genomics (2006) 0.98
Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. Atherosclerosis (2006) 0.97
Adult muscle 'stem' cells can be sustained in culture as free-floating myospheres. Exp Cell Res (2010) 0.97
Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol. J Biol Chem (2003) 0.97